Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance

Br J Dermatol. 2020 Dec;183(6):1117-1119. doi: 10.1111/bjd.19337. Epub 2020 Aug 9.

Authors

E Molinelli¹, V Brisigotti¹, O Simonetti¹, A Campanati¹, C Sapigni¹, G M D'Agostino¹, A Giacchetti², C Cota², A Offidani¹

Affiliations

¹ Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.
² Dermatological Unit, Institute for Treatment and Research INRCA IRCCS, Ancona, Italy.

PMID: 32579711
DOI: 10.1111/bjd.19337

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / adverse effects
Clindamycin* / adverse effects
Drug Resistance, Microbial
Hidradenitis Suppurativa* / drug therapy
Humans
Resorcinols / adverse effects

Substances

Anti-Bacterial Agents
Resorcinols
Clindamycin